PSY

Defiance Next Gen Altered Experience ETF
AUM$4.7M
Expense Ratio0.75%
NAV$5.93
Holdings2
InceptionMay 27, 2021

Price Chart

Key Statistics

Previous Close

N/A

Day Range

N/A

52-Week Range

N/A

Avg Volume

N/A

Dividend Yield

N/A

Expense Ratio

0.75%

AUM

$4.7M

Shares Outstanding

N/A

Sector Breakdown

SectorWeight %
Healthcare82.68%
Consumer Cyclical6.43%
Consumer Defensive5.65%
Real Estate5.25%

Country Allocation

CountryWeight %
Other100.00%

Fund Information

Category
Healthcare
Subcategory
Cannabis
Inception Date
May 27, 2021
Description
The index is a rules-based index that tracks the performance of a portfolio of companies conducting legal activities under the national laws of the applicable country related to medical psychedelics, medical cannabis, cannabis pharmaceuticals and cannabidiol derivatives, and ketamine. The fund uses a “replication” strategy to achieve its investment objective, it will invest in all of the component securities of the index in the same approximate proportions as in the index. It is non-diversified.

Similar ETFs

SymbolNameAUMExpense RatioHoldings
IWMiShares Russell 2000 ETF$70.17B0.19%1,934
XLVState Street Health Care Select Sector SPDR ETF$40.61B0.08%60
VHTVanguard Health Care ETF$19.80B0.09%411
COWZPacer US Cash Cows 100 ETF$18.40B0.49%103
VTWOVanguard Russell 2000 ETF$14.50B0.06%1,969

The Defiance Next Gen Altered Experience ETF (PSY) is an exchange-traded fund that launched on May 27, 2021. It currently manages $4.7M in assets under management. The fund charges an expense ratio of 0.75%. The fund holds 2 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 100.0% of the fund

RankSymbolNameWeight %SharesMarket Value
1Cash&OtherCash & Other100.00%5,043,031$5.0M
21914272D.TOALT HOUSE CANNABIS INC0.00%10,690$0

Detailed Returns

PeriodReturnETFCat. Avgvs Avg
1D
N/A
1W
N/A
1M
N/A
3M
N/A
6M
N/A
YTD
N/A
1Y
N/A
3Y
N/A
5Y
-77.76%

Moving Averages

20-Day MA

N/A

50-Day MA

N/A

200-Day MA

N/A

Price with Moving Averages

Support & Resistance

52-Week High

N/A

Current Price

N/A

52-Week Low

N/A

Current Yield

N/A

Annual Dividend

N/A

Frequency

N/A

Last Ex-Date

N/A

Dividends

No dividend data available for this ETF.

Category Comparison

MetricPSYHealthcare(223 ETFs)Cannabis(23 ETFs)
Fund Info
Expense Ratio0.75%0.60%0.68%
AUM$4.7M$1.25B$843.4M
Dividend Yield2.75%7.78%
Avg VolumeN/A769.9K781.5K
Holdings2182359
Performance
1-Month Return-3.02%-5.40%
6-Month Return+5.85%-11.39%
YTD Return+0.17%-10.06%
1-Year Return+16.65%+30.23%

Compare with Another ETF

Search for an ETF to compare with PSY: